tiprankstipranks
Trending News
More News >
Hangzhou Tigermed Consulting Co., Ltd. Class H (HK:3347)
:3347

Hangzhou Tigermed Consulting Co., Ltd. Class H (3347) Similar Stocks

Compare
1 Followers

Comparison Results

Name
Price
Analyst Price Target
Analyst Consensus
Market Cap
P/E Ratio
Yearly Gain
Top Analysts' Price Target
Smart Score
Follow
Hangzhou Tigermed Consulting Co., Ltd. Class H
HK$30.35
2 Buy
0 Hold
1 Sell
Moderate Buy
€39.74B
59.76
-0.40%
Shanghai Fosun Pharmaceutical (Group) Co
HK$15.70
0 Buy
1 Hold
0 Sell
Hold
HK$66.20B
13.96
32.79%
Livzon Pharmaceutical Group
HK$27.95
0 Buy
0 Hold
0 Sell
Moderate Sell
$31.86B
11.51
19.02%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:3347
Hangzhou Tigermed Consulting Co., Ltd. Class H
30.35
-0.12
-0.40%
HK:2196
Shanghai Fosun Pharmaceutical (Group) Co
15.70
3.88
32.79%
HK:1513
Livzon Pharmaceutical Group
27.95
4.47
19.02%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis